REPURPOSING OF CLINICALLY APPROVED GLUTAMATE ANTAGONISTS TO TREAT GLIOBLASTOMA

被引：0
|
作者：
Dasca, Julia Uriach [1 ,2 ]
Marashli, Samuel [1 ,2 ]
Holland, Eric C. [3 ]
Weller, Michael [1 ,2 ]
Wirsching, Hans-Georg [1 ,2 ]
机构：
[1] Univ Zurich, Zurich, Switzerland
[2] Univ Hosp, Zurich, Switzerland
[3] Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0966
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-35
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Repurposing clinically approved cephalosporins for tuberculosis therapy
    Santiago Ramón-García
    Rubén González del Río
    Angel Santos Villarejo
    Gaye D. Sweet
    Fraser Cunningham
    David Barros
    Lluís Ballell
    Alfonso Mendoza-Losana
    Santiago Ferrer-Bazaga
    Charles J. Thompson
    Scientific Reports, 6
  • [2] Repurposing clinically approved cephalosporins for tuberculosis therapy
    Ramon-Garcia, Santiago
    Gonzalez del Rio, Ruben
    Santos Villarejo, Angel
    Sweet, Gaye D.
    Cunningham, Fraser
    Barros, David
    Ballell, Lluis
    Mendoza-Losana, Alfonso
    Ferrer-Bazaga, Santiago
    Thompson, Charles J.
    SCIENTIFIC REPORTS, 2016, 6
  • [3] Repurposing the FDA-approved drug carbidopa to treat human cancers
    Ganapathy, Vadivel
    Babu, Ellappan
    Ramachandran, Sabarish
    Bhutia, Yangzom D.
    CANCER RESEARCH, 2016, 76
  • [4] REPURPOSING FDA APPROVED DRUGS TO TREAT MALARIA: UNDERSTANDING THE MECHANISM OF ACTION
    Goicoechea, Steven
    Gupta, Yash
    Simpson, Jessica
    Miller, Whelton A., III
    Rathi, Brijesh
    Durvasula, Ravi
    Kempaiah, Prakasha
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 284 - 284
  • [5] Repurposing Clinically Approved Drugs for the Treatment of Bacillus cereus, a Surrogate for Bacillus anthracis
    Amakawa, Masami
    Gunawardana, Soneli
    Jabbour, Alexy
    Hernandez, Alan
    Pasos, Chase
    Alameh, Saleem
    Shilman, Mikhail Martchenko
    Levitin, Anastasia
    ACS OMEGA, 2020, 5 (34): : 21929 - 21939
  • [6] Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer
    Li, Hongjian
    Tong, Christy Wing-Sum
    Leung, Yee
    Wong, Man-Hon
    To, Kenneth Kin-Wah
    Leung, Kwong-Sak
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [7] REPURPOSING GLUTAMATE RECEPTOR ANTAGONISTS TO PREVENT POST-TRAUMATIC OSTEOARTHRITIS
    Bonnet, C.
    Gilbert, S.
    Mason, D.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S170 - S171
  • [8] When Still Water Runs Deep: The Complexities of Clinically Repurposing FDA Approved Therapies
    Beninger, Paul
    Maron, Jill
    CLINICAL THERAPEUTICS, 2022, 44 (11) : 1427 - 1430
  • [9] In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
    Salaam, Ridwan Abiodun
    Afolayan, Funmilayo I. D.
    Olaniyi, Damilare Adebayo
    Oladokun, Sayo Ebenezer
    Ebuh, Rachael Pius
    Oyetunji, Ridwan Abiola
    SCIENTIFIC AFRICAN, 2025, 27
  • [10] Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs
    Mosa, Farag E. S.
    Alqahtani, Mohammed A.
    El-Ghiaty, Mahmoud A.
    Dyck, Jason R. B.
    Barakat, Khaled
    El-Kadi, Ayman O. S.
    DRUG DEVELOPMENT RESEARCH, 2024, 85 (05)
12345